Precision Medicine's Tipping Point with Ivan Rusilko Health Innovation Matters

Michael chats with Dr. Ivan Rusilko, a medical doctor, author, and pioneer in lifestyle medicine. In this episode, Michael and Ivan first discuss the state of precision medicine, then dive into mitocondriac cellular therapy, female hormone therapy, nicotinamide adenine dinucleotide (NAD) therapy, and the evolutions, science, narratives, and misperceptions surrounding those fields. Check out these documentaries featuring the work Ivan discusses in this episode: Parkinson's: https://vimeo.com/654359320  Burned: https://vimeo.com/767507931  MS: https://vimeo.com/764813906

Michael chats with Dr. Ivan Rusilko, a medical doctor, author, and pioneer in lifestyle medicine. In this episode, Michael and Ivan first discuss the state of precision medicine, then dive into mitocondriac cellular therapy, female hormone therapy, nicotinamide adenine dinucleotide (NAD) therapy, and the evolutions, science, narratives, and misperceptions surrounding those fields.

Check out these documentaries featuring the work Ivan discusses in this episode:

Parkinson’s: https://vimeo.com/654359320
Burned: https://vimeo.com/767507931
MS: https://vimeo.com/764813906

About Our Guest

Dr. Ivan Rusilko is a distinguished professional with a diverse background encompassing international fitness modeling, collegiate athletics, bodybuilding championships, and the prestigious title of two-time Mr. USA in both 2008 and 2010. Leveraging his extensive experience, Dr. Rusilko firmly believes in the integration of lifestyle and medicine as the key to achieving a prolonged and enhanced quality of life.

Dr. Rusilko’s practice is located in Miami Beach and helps individuals committed to their personal evolution. Employing a patient centric approach, he tailors treatments based on thorough diagnostics, addressing the physical, mental, and emotional dimensions unique to each individual. 

Podcast also available on PocketCasts, SoundCloud, Spotify, Google Podcasts, Apple Podcasts, and RSS.